NYSE$CYH

Community Health Systems Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Community Health Systems' second quarter results were affected by challenging operating dynamics including lower than anticipated volume, lower net revenue per adjusted admission, and significant contract labor costs.

Community Health Systems reported a net operating revenue of $2.934 billion and a net loss of $326 million, or $2.52 per share. Adjusted EBITDA was $253 million, including $8 million of pandemic relief funds.

  • Net operating revenues totaled $2.934 billion.
  • Net loss attributable to Community Health Systems, Inc. stockholders was $(326) million, or $(2.52) per share (diluted).
  • Adjusted EBITDA was $253 million, including $8 million of pandemic relief funds.
  • Net cash provided by operating activities was $53 million.

Headline financials

Total Revenue

$2.93B

Previous: $3.01B-2.4%
EPS (adj)

-$2.52

Previous: $0.23-1195.7%
Capital Expenditures

-$191M

Previous: -$212M+9.9%
Free Cash Flow

-$517M

Previous: -$206M-151.0%
Net Income

-$326M

Previous: $6M-5533.3%
Operating Income

$119M

Previous: $314M-62.1%
Gross Profit

$2.45B

Previous: $2.51B-2.4%
Cash & Equivalents

$346M

Previous: $1.25B-72.3%
Total Assets

$15.1B

Previous: $15.5B-3.0%
Stock-Based Comp

$3M

Previous: $5M-40.0%

Revenue & EPS history

CHS · Revenue · Quarterly

$2.93B

Q2 2022-2.4%vs Q2 2021
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Forward guidance

Community Health Systems projects net operating revenues between $12.2 billion and $12.5 billion and Adjusted EBITDA between $1.3 billion and $1.4 billion for the year ending December 31, 2022.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+1.7%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

55%

38 / 69 earnings

Positive

+52.4%

Q4 2022

Best reaction

-41.0%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%+6.3%+3.0%
Q4 2025+5.7%+4.5%-13.5%
Q3 2025+25.8%+29.1%-4.3%
Q2 2025+0.0%-0.7%+7.7%
Q1 2025+18.5%+11.1%+51.0%
Q4 2024+7.8%+9.9%-22.4%
Q3 2024-22.6%-25.3%-33.5%
Q2 2024+17.5%+27.9%+24.9%
Q1 2024+9.8%+11.1%+20.9%
Q4 2023-28.4%-27.7%-11.6%
Q3 2023-7.0%-18.0%+12.1%
Q2 2023+11.8%-8.4%-18.9%
Q1 2023-39.9%-42.3%-48.4%
Q4 2022+52.4%+56.3%-0.6%
Q3 2022+36.8%+35.4%+68.9%
Q2 2022-41.0%-39.6%-38.6%
Q1 2022-4.2%-19.1%-40.1%
Q4 2021-10.1%-21.3%-15.1%
Q3 2021+19.1%+28.9%+28.4%
Q2 2021-6.4%-8.3%-13.1%
Q1 2021+0.3%+15.2%+37.9%
Q4 2020-7.6%-9.3%+28.3%
Q3 2020+19.2%+30.3%+78.3%
Q2 2020+14.2%+26.4%+37.8%
Q1 2020-7.4%-22.9%-11.8%
Q4 2019+42.7%+27.8%-44.2%
Q3 2019-17.0%-30.4%-32.6%
Q2 2019+12.9%+25.8%+39.7%
Q1 2019-1.7%-4.0%-19.9%
Q4 2018+12.8%+21.4%+8.5%
Q3 2018-6.3%+20.0%+33.3%
Q2 2018+2.3%+9.5%+16.7%
Q1 2018+34.7%+26.5%+8.2%
Q4 2017-11.6%-15.0%-31.6%
Q3 2017-23.1%-26.6%-26.3%
Q2 2017-7.8%-8.8%+6.9%
Q1 2017+19.9%+11.7%+2.8%
Q4 2016+33.8%+33.6%+21.7%
Q3 2016+0.8%+4.9%+3.0%
Q2 2016-1.5%-0.5%-19.3%
Q1 2016-22.1%
Q4 2015-22.1%
Q3 2015-2.4%
Q2 2015+1.2%
Q1 2015-7.6%
Q4 2014+1.2%
Q3 2014-5.0%
Q2 2014-4.9%
Q1 2014-7.2%
Q4 2013+0.3%
Q3 2013-0.3%
Q2 2013+2.2%
Q1 2013+4.7%
Q4 2012+1.4%
Q3 2012+2.4%
Q2 2012-4.3%
Q1 2012+5.2%
Q4 2011+5.3%
Q3 2011-2.7%
Q2 2011-6.4%
Q1 2010-3.5%
Q1 2011+0.1%
Q4 2008+8.0%
Q4 2010+8.0%
Q3 2009+2.0%
Q3 2010+2.0%
Q4 2009+4.3%
Q2 2009+4.3%
Q2 2010+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro